TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 0 | -4 | -25 | -28 | -44 | -25 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/06 20:24 | 3/8/06 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kessel Larry | NY | D | M.d | 144 | 1.92 | 7 | 75 | 11 | 0 | 0 | -4 | -25 | -28 | -44 | |||||||||||
3/10/06 20:24 | 3/8/06 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kessel Larry | NY | D | S.d | -1,290 | 17.20 | 7 | -75 | -87 | 11 | 0 | 0 | -4 | -25 | -28 | -44 | ||||||||||
1/12/04 17:21 | 1/8/04 | NVDL | Novadel Pharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Kessel Larry | NJ | D | P.d | 21 | 1.05 | 0 | 20 | New | 20 | D | |||||||||||||||
8/13/03 13:26 | 8/11/03 | CYPB | Cypress Bioscience Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kessel Larry | CA | D | P.m | 67 | 4.44 | 0 | 15 | 10 | 169 | D | |||||||||||||||
8/8/03 17:20 | 8/7/03 | CYPB | Cypress Bioscience Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kessel Larry | CA | D | P | 99 | 4.95 | 0 | 20 | 15 | 154 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |